Rapport Therapeutics CEO Ceesay sells $86,565 in company stock - Investing.com India
Source: Investing.com India ·
Rapport Therapeutics CEO Ceesay sells $86,565 in company stock Investing.com India
BestAIBroker analysis
- Finance-aware sentiment: slightly negative (-0.30 on a -1 to +1 scale).
- Event classification: OTHER.
- Market importance score: 28/100, weighting entity relevance, source credibility, multi-outlet coverage and recency.
- Symbols referenced: RAPP.